News|Articles|August 4, 2026
5 Hepatology Headlines You Missed in July 2026
Author(s)Alex Hillenbrand
Fact checked by: Chelsie Derman
Hepatology in July 2026: Odevixibat misses phase 3 primary endpoint, zabopegdutide shows early MASH benefit, plus a new Wilson disease NDA
Advertisement
Advertisement
July brought mixed trial results across hepatology, a new regulatory filing, and fresh data on gaps in patient awareness.
Advertisement
Advertisement